JYNT on Nasdaq

JOINT Corp

In its 2026 annual report the company says: “We are a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We have created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by us that employ licensed chiropractors. Our model enables us to price our services below most competitors’ pricing for similar services and below most insurance co-payment levels (i.e., below the patient co-payment required for an insurance-covered service).”3 It is headquartered in Scottsdale, Arizona.1 Its shares trade on Nasdaq under the symbol JYNT.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Acacia Research, Digital Turbine or Royalty Management Holding Corp, or pick any stock.

  • TickerJYNT on Nasdaq1
  • IndustryPatent Owners & Lessors1
  • HeadquartersScottsdale, Arizona1
  • Incorporated inDE2
  • Business address16767 N Perimeter Drive, Suite 110, Scottsdale, Az 852602
  • Filer categoryNon-accelerated filer, Smaller reporting company2

We are a growing franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. We seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry. We delivered over 14.4 million patient visits in 2025, down from 14.7 million patient visits in 2024, generating over $532.4 million and $530.3 million of system-wide sales, respectively, across our highly franchised network. We will continue the franchise-focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad. We strive to accomplish our mission by making quality care readily available and affordable in a retail setting. We have created a growing network of modern, consumer-friendly chiropractic clinics operated or managed by franchisees and by us that employ licensed chiropractors.…3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-1.7%Operating margin4
5.3%Net margin4
5.2%Revenue growth, 20254
19.3%Return on equity4
$334.7KFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Royalty brought in 60% of the revenue JOINT Corp broke down this way in fiscal 2025.

  1. Royalty$33.2M460%up 3% from 2024
  2. Advertising$10.5M419%up 14% from 2024
  3. Technology Service$6.0M411%up 6% from 2024
  4. Franchise$3.4M46%up 12% from 2024
  5. Product and Service, Other$1.8M43%down 15% from 2024
Products and services by year
Products and services20242025
Royalty$32.1M$33.2M
Advertising$9.2M$10.5M
Technology Service$5.7M$6.0M
Franchise$3.0M$3.4M
Product and Service, Other$2.2M$1.8M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue19¢$11.2M
  • Selling, general and admin76¢$44.6M
  • Income tax0¢$38.7K
  • Profit5¢$2.9M

Out of $54.9M in revenue.4

Where each dollar of operating cash went, fiscal 2025

  • Capital spending12¢$1.5M
  • Share buybacks88¢$11.3M

Out of $1.8M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.4

Financial statements

Revenue56784$54.9M in 2025+13% since 2019
0$50.0M$100.0M$150.0M2019: $48.5M$48.5M20192020: $58.7M$58.7M2020+21%2021: $80.0M$80.0M2021+36%2022: $101.3M$101.3M2022+27%2023: $117.7M$117.7M2023+16%2024: $52.2M$52.2M2024−56%2025: $54.9M$54.9M2025+5%
Operating income56794-$913.4K in 2025
-$2.5M0$2.5M$5.0M$7.5M2019: $3.4M$3.4M20192020: $5.5M$5.5M2020+61%2021: $6.1M$6.1M2021+12%2022: -$1.9M-$1.9M20222023: $318.3K$318.3K20232024: -$1.9M-$1.9M20242025: -$913.4K-$913.4K2025−52%
Net income56784$2.9M in 2025−13% since 2019
-$10.0M0$10.0M$20.0M2019: $3.3M$3.3M20192020: $13.2M$13.2M2020+296%2021: $7.6M$7.6M2021−43%2022: $626.7K$626.7K2022−92%2023: -$9.8M-$9.8M20232024: -$5.8M-$5.8M2024−41%2025: $2.9M$2.9M2025

Every line of the income statement as filed: the last 2 fiscal years (annual) or 8 quarters (quarterly), latest first.4

Period ending2025-12-312024-12-31
Total revenues$54.9M$52.2M
Total cost of revenues$11.2M$11.5M
Selling and marketing expenses$13.3M$11.0M
Depreciation and amortization$1.6M$1.4M
General and administrative expenses$29.6M$30.1M
Total selling, general and administrative expenses$44.6M$42.5M
Net loss on disposition or impairment$7.9K$66.0K
Loss from continuing operations-$913.4K-$1.9M
Other income, net$683.9K$280.3K
Loss from continuing operations before income tax expense-$229.5K-$1.6M
Income tax expense$38.7K$5.6K
Net loss from continuing operations-$268.2K-$1.6M
Income (loss) from discontinued operations before income tax expense$3.2M-$4.0M
Income tax expense from discontinued operations$25.2K$210.3K
Net income (loss) from discontinued operations$3.2M-$4.2M
Net income (loss)$2.9M-$5.8M
Basic (in dollars per share)-$0-$0
Diluted (in dollars per share)-$0-$0
Basic (in dollars per share)$0-$0
Diluted (in dollars per share)$0-$0
Net income (loss) per common share, basic (in dollars per share)$0.19-$0.39
Net income (loss) per common share, diluted (in dollars per share)$0.19-$0.38
Basic weighted average shares outstanding (in shares)15.1M shares14.9M shares
Diluted weighted average shares outstanding (in shares)15.2M shares15.1M shares

Compare JOINT Corp with another company

Corporate structure

JOINT Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of JOINT Corp

  • BlackRock Filed SCHEDULE 13G/A on JOINT Corp, latest Jul 28, 2026 (10 filings since Jan 26, 2022)
  • Charles E. Jobson Filed SCHEDULE 13G/A on JOINT Corp, latest May 15, 2026 (5 filings since Jun 11, 2025)
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on JOINT Corp, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
  • Bandera Partners LLC Filed SCHEDULE 13D/A on JOINT Corp, latest Mar 16, 2026 (11 filings since Feb 14, 2022)
  • Skylands Capital, LLC Filed SCHEDULE 13G on JOINT Corp, latest Jan 8, 2026 (2 filings since Jul 10, 2025)
  • MILLENNIUM MANAGEMENT LLC Filed SC 13G/A on JOINT Corp, latest Jan 12, 2024 (2 filings since Jan 13, 2023)
  • ALGER ASSOCIATES INC Filed SC 13G/A on JOINT Corp, latest Jun 10, 2022 (4 filings since Oct 8, 2021)
  • SW Investment Management LLC Filed SC 13G/A on JOINT Corp, latest Feb 14, 2022
  • JOINT Corp Scottsdale, Arizona

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What JOINT Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Construction in progress$990.1K4 Dec 31, 2025$751.9K4 Dec 31, 2024+31.7%
Property and equipment, net$3.2M4 Dec 31, 2025$3.2M4 Dec 31, 2024−1.5%
Operating-lease assets (leased space)$1.6M4 Dec 31, 2025$555.5K4 Dec 31, 2024+183.0%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$23.6M4 Dec 31, 2025$25.1M4 Dec 31, 2024−5.8%

Properties, in its own words

We lease the property for our corporate headquarters and all of the properties for our company-owned or managed clinics. As of December 31, 2025, we leased 80 facilities in which we operate, with our corporate headquarters being the only leased property that will remain after the completion of our refranchising strategy. We are obligated under three additional leases for facilities in which we have ceased clinic operations.

Our corporate headquarters are located at 16767 N. Perimeter Center Drive, Suite 110, Scottsdale, Arizona 85260. The term of our lease for this location expires on May 31, 2031. The primary functions performed at our corporate headquarters are finance and accounting, treasury, marketing, operations, human resources, information systems support and legal.

The rest of Item 2

We are also obligated under non-cancellable leases for the clinics that we own or manage. Our clinics are on average 1,200 square feet. Our clinic leases generally have an initial term of five years, include one to two options to renew the term for five years each, and require us to pay a proportionate share of real estate taxes, insurance, common area maintenance charges and other operating costs.

Item 2 of the 10-K filed Mar 13, 2026.3

Leadership

Who has led JOINT Corp, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (21)

Timeline

  1. Oct 1, 20268-K Entered a material agreement39
  2. Aug 6, 20268-K Results of operations; Regulation FD disclosure40
  3. May 21, 20268-K Shareholder vote41
  4. May 7, 20268-K Entered a material agreement; Results of operations; New debt or obligation42
  5. May 1, 20268-K Other events43
  6. Apr 24, 20268-K Entered a material agreement44
  7. Mar 12, 20268-K Results of operations; Regulation FD disclosure45
  8. Jan 12, 20268-K Entered a material agreement46
  9. Jan 9, 20268-K Entered a material agreement47
  10. Dec 11, 20258-K Entered a material agreement; Ended a material agreement48
  11. Nov 6, 20258-K Entered a material agreement; Results of operations; Regulation FD disclosure49
  12. Oct 6, 20258-K Entered a material agreement; New debt or obligation50
  13. Jul 13, 2016New chief executive Peter D. Holt becomes CEO12
  14. Nov 10, 2014New chief executive John B. Richards becomes CEO13

Calendar

Coming up

  1. Nov 5, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.02 a share, on Nov 6, 2025.51

When it reported results

  1. Aug 6, 2026Reported quarterly or annual results40
  2. May 7, 2026Reported quarterly or annual results42
  3. Mar 12, 2026Reported quarterly or annual results45
  4. Nov 6, 2025Reported quarterly or annual results49
  5. Aug 7, 2025Reported quarterly or annual results52
  6. Jul 30, 2025Reported quarterly or annual results53
  7. May 8, 2025Reported quarterly or annual results54
  8. Mar 13, 2025Reported quarterly or annual results55

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

221 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 52 major events, 87 insider forms, 39 large holders, 19 other. The latest 20:

  1. Oct 1, 20268-K EDGAR
  2. Aug 7, 202610-Q EDGAR
  3. Aug 6, 20268-K EDGAR
  4. Jul 28, 2026SCHEDULE 13G/A EDGAR
  5. Jun 12, 20264 EDGAR
  6. Jun 3, 20264 EDGAR
  7. Jun 3, 20263 EDGAR
  8. May 22, 20264 EDGAR
  9. May 22, 20264 EDGAR
  10. May 22, 20264 EDGAR
  11. May 22, 20264 EDGAR
  12. May 21, 20268-K EDGAR
  13. May 15, 2026SCHEDULE 13G/A EDGAR
  14. May 14, 20264 PRIMARY DOCUMENT EDGAR
  15. May 8, 202610-Q EDGAR
  16. May 7, 20268-K EDGAR
  17. May 1, 20268-K EDGAR
  18. Apr 24, 20268-K EDGAR
  19. Apr 23, 2026SCHEDULE 13G/A EDGAR
  20. Apr 23, 20264 PRIMARY DOCUMENT EDGAR

The 221 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

78 open-market trades by officers, directors and large owners since October 2021: 78 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 13, 2026JOBSON CHARLES E10% ownerBuy20,375$8.57$174.6KForm 4
May 12, 2026JOBSON CHARLES E10% ownerBuy127,676$8.57$1.1MForm 4
Apr 21, 2026JOBSON CHARLES E10% ownerBuy509$8.58$4.4KForm 4
Feb 12, 2026JOBSON CHARLES E10% ownerBuy15,397$8.50$130.9KForm 4
Feb 11, 2026JOBSON CHARLES E10% ownerBuy448$8.70$3.9KForm 4
Jan 26, 2026JOBSON CHARLES E10% ownerBuy725$10.00$7.2KForm 4
Jan 23, 2026JOBSON CHARLES E10% ownerBuy16,753$10.00$167.5KForm 4
Jan 6, 2026JOBSON CHARLES E10% ownerBuy5,240$8.89$46.6KForm 4
Jan 2, 2026JOBSON CHARLES E10% ownerBuy1,393$8.70$12.1KForm 4
Dec 31, 2025JOBSON CHARLES E10% ownerBuy11$8.70$96Form 4
Dec 5, 2025JOBSON CHARLES E10% ownerBuy10,000$8.41$84.1KForm 4
Dec 1, 2025JOBSON CHARLES E10% ownerBuy13,000$8.41$109.3KForm 4
Nov 25, 2025JOBSON CHARLES E10% ownerBuy2,081$8.43$17.5KForm 4
Nov 24, 2025JOBSON CHARLES E10% ownerBuy4,680$8.36$39.1KForm 4
Nov 21, 2025JOBSON CHARLES E10% ownerBuy10,000$8.50$85.0KForm 4
Aug 20, 2025Grandpre Christopher MDirectorBuy10,000$10.41$104.1KForm 4
Aug 18, 2025Grandpre Christopher MDirectorBuy10,000$10.70$107.0KForm 4
Aug 15, 2025Grandpre Christopher MDirectorBuy14,388$10.88$156.5KForm 4
Sep 21, 2023Bandera Partners LLC10% ownerBuy218,101$9.60$2.1MForm 4
Sep 20, 2023Bandera Partners LLC10% ownerBuy22,666$9.50$215.3KForm 4

All 78 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Sanjiv RazdanPresident and Chief Executive Officer$550.0K$1.8M64
2025Jake SingletonFormer Chief Financial Officer$194.3K$646.9K64
2025Scott BowmanChief Financial Officer$208.5K$599.2K64
2024Sanjiv RazdanPresident and Chief Executive Officer$127.7K$864.2K64
2024Jake SingletonFormer Chief Financial Officer$330.3K$672.6K64

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 84. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Bandera Partners LLC3,937,296$34.6M12.2%No change
Skylands Capital, LLC895,572$7.9M1.0%+2,377
JCP Investment Management, LLC593,906$5.2M2.8%No change
Vanguard Capital Management LLC557,053$4.9M0.0%−38,554
First Foundation Advisors334,865$2.9M0.1%−2,986
BlackRock, Inc.288,615$2.5M0.0%−465,906
Russell Investments Group, Ltd.285,310$2.5M0.0%−36,548
Jane Street Group, LLC235,851$2.1M0.0%+174,025
Vanguard Portfolio Management LLC224,740$2.0M0.0%−52,904
Renaissance Technologies LLC219,478$1.9M0.0%−9,100
Geode Capital Management, LLC153,817$1.4M0.0%−133,594
Dimensional Fund Advisors LP150,198$1.3M0.0%−3,556
Douglass Winthrop Advisors, LLC147,100$1.3M0.0%−2,000
Citadel Advisors LLC139,473$1.2M0.0%+97,899
Verus Capital Partners, LLC122,065$1.1M0.1%−8,640
Goldman Sachs Group Inc119,565$1.0M0.0%−1,815
D. E. Shaw & Co., Inc.115,698$1.0M0.0%+8,939
Squarepoint Ops LLC105,467$926.0K0.0%+27,633
Millennium Management LLC105,152$923.2K0.0%New
Vanguard Fiduciary Trust Co78,717$691.1K0.0%−7,183
Point72 Asset Management, L.P.76,519$671.8K0.0%New
State Street Corp72,351$635.2K0.0%−213,260
Aqr Capital Management LLC69,536$610.5K0.0%+49,863
Marshall Wace, Llp53,173$466.9K0.0%New
RBF Capital, LLC50,749$445.6K0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How JOINT Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARJOINT Corp1
  • CIK0001612630
  • Employer ID (EIN)90-05441603
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company3
  • Incorporated inDelaware3
  • Fiscal year endsDecember 311
  • Industry code (SIC)6794 Patent Owners & Lessors1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business address16767 N Perimeter Drive, Suite 110, Scottsdale, AZ 852601
  • Phone480 245 59601
  • Shares outstanding14,143,154 as of Aug 3, 202611
  • Public float$172.5M as of Jun 30, 20253
  • AuditorBDO USA, P.C., Phoenix, Arizona PCAOB ID 243; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceJul 11, 20141
  • Filings624 in all: 4 (239), 8-K (138), SC 13G/A (42), 10-Q (36), 3 (29), SC 13G (17), CORRESP (14), 10-K (12)1
    All 39 form types

    DEF 14A (12), 8-K/A (10), UPLOAD (8), S-1/A (6), SCHEDULE 13G/A (6), S-8 (5), SC 13D/A (5), 3/A (3), 5 (3), DEFA14A (3), NT 10-Q (3), SCHEDULE 13D/A (3), SCHEDULE 13G (3), 10-K/A (2), 10-Q/A (2), 144 (2), 4/A (2), 424B1 (2), DEFR14A (2), EFFECT (2), S-1 (2), SC 13D (2), 8-A12B (1), CERTNAS (1), DRS (1), DRS/A (1), DRSLTR (1), NT 10-K (1), S-1MEF (1), SC 14N (1), SC 14N/A (1)

  • Latest filingsAnnual report (10-K) Mar 13, 2026
    Quarterly report (10-Q) Aug 7, 2026
    Proxy statement (DEF 14A) Apr 7, 2026
    Latest 8-K (8-K) Oct 1, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.001 Par Value Per ShareJYNTNASDAQ

From the cover page of the 10-K filed Mar 13, 2026 (Section 12(b) of the Exchange Act).3

Risk factors and legal proceedings

The risks JOINT Corp names in Item 1A of its 10-K filed Mar 13, 2026: 40 risks under these headings, as written.3

  • RISKS RELATED TO OPERATING OUR BUSINESS
  • The nationwide labor shortage has negatively impacted our ability to recruit chiropractors and other qualified personnel, and the measures we have taken in response have reduced our net revenues.
  • Inflation has led to increased labor costs and interest rates and may lead to reduced discretionary spending, all of which may negatively impact our business.
  • New clinics, once opened, may not be profitable, and the increases in average clinic sales and comparable clinic sales that our franchisees have experienced in the past may not be indicative of future results.
  • Our failure to manage our growth effectively could harm our business and operating results.
  • Our expansion into new markets may be more costly and difficult than we currently anticipate, which would result in slower growth than we expect.
  • Opening new clinics in existing markets may negatively affect revenue at existing clinics.
  • Damage to our reputation or our brand in existing or new markets could negatively impact our business, financial condition and results of operations.
  • Our marketing programs may not be successful.
  • We will be subject to risks associated with leasing space subject to long-term non-cancelable leases for clinics that we intend to operate.
  • Changes in economic conditions and adverse weather and other unforeseen conditions could materially affect our ability to maintain or increase sales at our clinics.
  • RISKS RELATED TO USE OF THE FRANCHISE BUSINESS MODEL
The other 30 risks
  • Our dependence on the success of our franchisees exposes us to risks, including the loss of royalty revenue and harm to our brand.
  • Our franchisees are independent operators over whom we have limited control.
  • We are subject to the risk that our franchise agreements may be terminated or not renewed.
  • Our franchisees may not meet timetables for opening their clinics, which could reduce the royalties we receive.
  • Our regional developers are independent operators over whom we have limited control.
  • FINANCIAL RISK FACTORS
  • Our level of debt could impair our financial condition and ability to operate.
  • We have identified a material weakness in our internal control over financial reporting. If we fail to maintain an effective system of internal controls over financial reporting, we may not be able to accurately report our financial results, prevent fraud, or maintain investor confidence.
  • Our balance sheet includes intangible assets and goodwill. A decline in the estimated fair value of an intangible asset or a reporting unit could result in an impairment charge recorded in our operating results, which could be material.
  • Our balance sheet includes a significant number of long-lived assets in our corporate clinics, including operating lease right-of-use assets and property, plant and equipment. A decline in the current and projected cash flows in our corporate clinics could result in impairment charges, which could be material.
  • Our increased reliance on sources of revenue other than from company-owned or managed clinics exposes us to risks including the loss of revenue and reduction of working capital.
  • We have experienced net losses and may not achieve or sustain profitability in the future.
  • Any audit by the IRS with respect to our receipt of an employee retention credit (“ERC”) under The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) could result in additional taxes or costs to our company.
  • RISKS RELATED TO INDUSTRY DYNAMICS AND COMPETITION
  • Our clinics and chiropractors compete for patients in a highly competitive environment that may make it more difficult to increase patient volumes and revenues.
  • Our success is dependent on the chiropractors who control the PCs, or PC owners, with whom we enter into management services agreements, and we may have difficulty locating qualified chiropractors to replace PC owners.
  • RISKS RELATED TO STATE REGULATION OF THE CORPORATE PRACTICE OF CHIROPRACTIC
  • Our management services agreements, under which we provide non-clinical services to affiliated PCs, could be challenged by a state or chiropractor under laws regulating the practice of chiropractic. Some state chiropractic boards have made inquiries concerning our business model or have proposed or adopted changes to their rules that could be interpreted to pose a threat to our business model.
  • RISKS RELATED TO OTHER LEGAL AND REGULATORY MATTERS
  • Uncertainties with federal regulations under the new presidential administration expanding the meaning of “joint employer” and evolving state laws increase our potential liability for employment law violations by our franchisees and the likelihood that we may be required to participate in collective bargaining with our franchisees’ employees.
  • An increased regulatory focus on the establishment of fair franchise practices could increase our risk of liability in disputes with franchisees and the risk of enforcement actions and penalties.
  • We conduct business in a heavily regulated industry, and if we fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes to our operations.
  • Our chiropractors are subject to ethical guidelines and operating standards which, if not complied with, could adversely affect our business.
  • We, along with our affiliated PCs and their chiropractors, are subject to malpractice and other similar claims and may be unable to obtain or maintain adequate insurance against these claims.
  • Events or rumors relating to our brand names or our ability to defend successfully against intellectual property infringement claims by third parties could significantly impact our business.
  • RISKS RELATED TO INFORMATION TECHNOLOGY, CYBERSECURITY AND DATA PRIVACY
  • Our failure to comply with applicable federal and state data privacy and security laws could result in civil or criminal sanctions or damage awards, and the proliferation of such laws increases our costs of compliance.
  • Our business model depends on proprietary and third-party management information systems that we use to, among other things, track financial and operating performance of our clinics, and any failure to successfully design and maintain these systems or implement new systems could materially harm our operations.
  • If we fail to properly maintain the integrity of our data or to strategically implement, upgrade or consolidate existing information systems, our reputation and business could be materially adversely affected.
  • If our security systems are breached, we may face civil liability and public perception of our security measures could be diminished, either of which would negatively affect our ability to attract and retain patients.
  • We are subject to a number of risks related to credit card and debit card payments we accept.
  • GENERAL RISK FACTORS
  • We have restated our Previously Issued Financial Statements, which may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on our stock price.
  • Short-selling strategies and negative opinions posted on the internet may drive down the market price of our common stock and could result in class action lawsuits.
  • Future sales of our common stock may depress our stock price and our share price may decline due to the large number of shares eligible for future sale or exchange.
  • Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.

Legal proceedings

Information regarding our legal proceedings is discussed in Note 10, Commitments and Contingencies in the Notes to the consolidated financial statements, which is incorporated herein by reference.

The opening of Item 3, Legal Proceedings.3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
    SEC EDGAROther events
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64